Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of New Biomarkers and Potential Therapeutic Targets in Clinical Osteoporosis Using Omics Technologies

NCT06525688 is registered in ClinicalTrials.gov with National and Kapodistrian University of Athens as lead sponsor.

NCT NCT06525688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06525688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of New Biomarkers and Potential Therapeutic Targets in Clinical Osteoporosis Using Omics Technologies
Lead sponsor
National and Kapodistrian University of Athens
Phase
Observational
Overall status
Unknown status
Start date
July 3, 2024
Completion date
December 30, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis fracture, osteoporosis, postmenopausal, osteoporosis, severe